natural

Turning The Spotlight On The FDA – Why Kratom Is Still A Target

Last week, Hon. Aumua Amata Coleman Radewagen of American Samoa presented a Washington Times article in the House of Representatives. This article, “An Excuse For Crushing Kratom: The FDA’s Undue Scrutiny Is Unscientific,” highlights the inappropriate and unnecessary targeting of kratom by the FDA. One of the many arguments in support of kratom is the …

Turning The Spotlight On The FDA – Why Kratom Is Still A Target Read More »

Kratom – Evaluating The Perception Of A “Controversial” Drug

Over the past few years, Kratom has become increasingly popular in the public eye. As is the case with most “new” things, news agencies attempt to look at it with a critical eye, attempting to trade page views for manufactured controversy. This, in turn, activates the concerned parent contingent, intent on finding the next PTA …

Kratom – Evaluating The Perception Of A “Controversial” Drug Read More »